Closed Loop Glucose Control in a Simulated ICU Setting
NCT: NCT07646067 · NOT_YET_RECRUITING
Brief Summary
This is a proof of concept safety study of a rule-based closed loop glucose control system designed for use in the intensive care unit setting. The persons with type 1 and type 2 diabetes in this study will have their glucose controlled to a range of 100-140 mg/dL by a fully autonomous novel rule-based closed loop glucose control system for a period of 24 hours. The subjects will consume three standardized meals and receive a continuous intravenous infusion of dextrose (D-glucose) during the 24 hour study period. Meals will not be announced to the glucose control system.
Frequently Asked Questions
What is Closed Loop Glucose Control in a Simulated ICU Setting?
Closed Loop Glucose Control in a Simulated ICU Setting is a clinical trial registered under NCT07646067. Current status: NOT_YET_RECRUITING.
What is the status of NCT07646067?
The current status of NCT07646067 (Closed Loop Glucose Control in a Simulated ICU Setting) is: NOT_YET_RECRUITING.
When did Closed Loop Glucose Control in a Simulated ICU Setting start?
Closed Loop Glucose Control in a Simulated ICU Setting started on 2026-07.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.